Conference Reports for NATAP
66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back
 
Safety and Tolerability of Grazoprevir/Elbasvir in Patients With Chronic Hepatitis C (HCV) Infection: Integrated Analysis of Phase 2-3 Trials
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Geoffrey M Dusheiko